News Do you have groundbreaking technology that can diagnosis or treat disorders of nervous system? We are pleased to share an exciting new funding opportunity from the…Super UserOctober 3, 2022
News SISU Global Names One of MedTech’s 100 Largest Players #KeiretsuBacked Sisu Global named in the list of the 100 Most Influential…Super UserOctober 3, 2022
News NIIMBL Releases the First Industry-wide Biomanufacturing Readiness Level Framework for Biologics NEWARK, Del., Sept. 29, 2022 /PRNewswire/ -- The National Institute for Innovation…Super UserOctober 3, 2022
News SOLVE FSHD Invests US $1 Million in miRecule to Accelerate Development of Best-in-Class Antibody-RNA Conjugate to Treat Facioscapulohumeral Muscular Dystrophy GAITHERSBURG, Maryland and VANCOUVER, British Columbia – September 29, 2022 – miRecule,…Super UserOctober 3, 2022
News Administrator Guzman Applauds Passage of Small Business Innovation Research (SBIR) Program Reauthorization, Committing to Scientific and Technology Innovation WASHINGTON – Administrator Isabella Casillas Guzman, head of the U.S. Small Business…Super UserSeptember 30, 2022
News Commerce secretary, local experts project how recession would affect life sciences Some economists say yes — and predict it's going to be bad…Super UserSeptember 29, 2022
News Additional Information on New NIH MedTech Program: Incubator hubs will provide subawards to technology innovation teams and aim to accelerate medical devices to treat, diagnose nervous system disorders – The LaunchPort Newswise — The National Institutes of Health, through its Blueprint MedTech program, has established…Super UserSeptember 29, 2022
News MaxCyte Signs Strategic Platform License with Vertex Pharmaceuticals to Advance CRISPR/Cas9-based Gene-editing Program Vertex Pharmaceuticals will continue to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to…Super UserSeptember 29, 2022
News Altimmune Announces First Dosing of All Subjects in Phase 2 MOMENTUM Trial of Pemvidutide in Subjects with Obesity or Overweight Twenty-four week interim analysis on approximately 160 subjects planned for Q1 2023…Super UserSeptember 29, 2022
News Emmes Acquires Clinical Edge The Company's Fifth Acquisition Deepens Ophthalmology Credentials and Enhances Global Reach ROCKVILLE,…Super UserSeptember 29, 2022